share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  06/03 13:41
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
vertex pharmaceuticals inc高管Tatsis Ourania計劃於2024年06月03日賣出2,175股普通股,市值約為1,000,500美元。將賣出的股份是通過限制性股票發放獲得,作為其中兩次補償的一部分,其中740股在2024年02月17日獲得,另外1,435股在2024年02月20日從發行人獲得。此次計劃的出售是在過去三個月內進行的一筆交易之後,該交易共售出4,600股,總收益為2,033,158.5美元。
vertex pharmaceuticals inc高管Tatsis Ourania計劃於2024年06月03日賣出2,175股普通股,市值約為1,000,500美元。將賣出的股份是通過限制性股票發放獲得,作為其中兩次補償的一部分,其中740股在2024年02月17日獲得,另外1,435股在2024年02月20日從發行人獲得。此次計劃的出售是在過去三個月內進行的一筆交易之後,該交易共售出4,600股,總收益為2,033,158.5美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息